The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
Ceased 3
  • 1
    Roberts, Ann Elizabeth
    Company Director born in July 1962
    Individual
    Officer
    2022-07-21 ~ 2023-09-01
    OF - Director → CIF 0
  • 2
    Duncan, Jarrett Blair
    Ceo & General Counsel born in April 1977
    Individual
    Officer
    2019-11-14 ~ 2022-07-20
    OF - Director → CIF 0
  • 3
    Ambridge, Trevor John
    Company Director born in May 1959
    Individual (3 offsprings)
    Officer
    2023-09-01 ~ 2024-05-01
    OF - Director → CIF 0
parent relation
Company in focus

RS PROGRESS LTD.

Previous name
RS ONCOLOGY LTD - 2022-07-08
Standard Industrial Classification
66210 - Risk And Damage Evaluation
Brief company account
Par Value of Share
Class 1 ordinary share
12022-12-01 ~ 2023-12-31
Debtors
130,164 GBP2023-12-31
117,052 GBP2022-11-30
Cash at bank and in hand
183,231 GBP2023-12-31
43,044 GBP2022-11-30
Current Assets
313,395 GBP2023-12-31
160,096 GBP2022-11-30
Creditors
Current
286,418 GBP2023-12-31
156,715 GBP2022-11-30
Net Current Assets/Liabilities
26,977 GBP2023-12-31
3,381 GBP2022-11-30
Total Assets Less Current Liabilities
26,977 GBP2023-12-31
3,381 GBP2022-11-30
Equity
Called up share capital
1 GBP2023-12-31
1 GBP2022-11-30
Retained earnings (accumulated losses)
26,976 GBP2023-12-31
3,380 GBP2022-11-30
Equity
26,977 GBP2023-12-31
3,381 GBP2022-11-30
Average Number of Employees
212022-12-01 ~ 2023-12-31
32021-12-01 ~ 2022-11-30
Amounts Owed by Group Undertakings
Current
13,058 GBP2023-12-31
30,863 GBP2022-11-30
Other Debtors
Current, Amounts falling due within one year
117,106 GBP2023-12-31
86,189 GBP2022-11-30
Debtors
Current, Amounts falling due within one year
130,164 GBP2023-12-31
117,052 GBP2022-11-30
Trade Creditors/Trade Payables
Current
11,030 GBP2023-12-31
Other Taxation & Social Security Payable
Current
86,954 GBP2023-12-31
72,007 GBP2022-11-30
Other Creditors
Current
188,434 GBP2023-12-31
84,708 GBP2022-11-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
5,880 GBP2023-12-31
5,880 GBP2022-11-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1 shares2023-12-31

  • RS PROGRESS LTD.
    Info
    RS ONCOLOGY LTD - 2022-07-08
    Registered number 12315627
    The St Botolph Building, 138, Houndsditch, London EC3A 7AR
    Private Limited Company incorporated on 2019-11-14 (5 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-28
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.